Literature DB >> 21726990

A delicate dance: host response to mycobacteria.

Kassidy K Huynh1, Shilpa A Joshi, Eric J Brown.   

Abstract

Mycobacterium tuberculosis is an enormously successful human pathogen that can infect its host for decades without causing clinical disease, only to reactivate when host immunity is compromised. A normal immune response thus contains bacterial spread without inducing sterilizing immunity, therefore benefitting both host and pathogen. Recent work has begun to outline the complexity of this host-pathogen interaction and to reveal how the homeostatic balance between the two is achieved. This review focuses on two significant aspects of this delicate dance: the host's initial innate response and the mature granuloma that later contains the pathogen. Here, we review the fine balance of inflammatory events triggered or controlled by both the host and bacteria and implications for the survival of each.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726990     DOI: 10.1016/j.coi.2011.06.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  51 in total

Review 1.  Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.

Authors:  Robert L Hunter
Journal:  Tuberculosis (Edinb)       Date:  2016-01-02       Impact factor: 3.131

2.  Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.

Authors:  Patrick Vianna Garcia; Letícia Montanholi Apolinário; Petra Karla Böckelmann; Iseu da Silva Nunes; Nelson Duran; Wagner José Fávaro
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  Advancing host-directed therapy for tuberculosis.

Authors:  Robert S Wallis; Richard Hafner
Journal:  Nat Rev Immunol       Date:  2015-03-13       Impact factor: 53.106

4.  Heme Oxygenase-1 Regulates Inflammation and Mycobacterial Survival in Human Macrophages during Mycobacterium tuberculosis Infection.

Authors:  Caitlyn R Scharn; Angela C Collins; Vidhya R Nair; Chelsea E Stamm; Denise K Marciano; Edward A Graviss; Michael U Shiloh
Journal:  J Immunol       Date:  2016-04-22       Impact factor: 5.422

5.  Differential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria.

Authors:  Bryan E Hart; Richard I Tapping
Journal:  J Immunol       Date:  2012-10-26       Impact factor: 5.422

Review 6.  Effect of Helicobacter pylori and Helminth Coinfection on the Immune Response to Mycobacterium tuberculosis.

Authors:  Javier Andrés Bustamante-Rengifo; Miryam Astudillo-Hernández; María Del Pilar Crespo-Ortiz
Journal:  Curr Microbiol       Date:  2021-07-12       Impact factor: 2.188

7.  Mycobacterium marinum SecA2 promotes stable granulomas and induces tumor necrosis factor alpha in vivo.

Authors:  Brigitte Y Watkins; Shilpa A Joshi; David A Ball; Hadley Leggett; Summer Park; Janice Kim; Cary D Austin; Andres Paler-Martinez; Min Xu; Kenneth H Downing; Eric J Brown
Journal:  Infect Immun       Date:  2012-07-30       Impact factor: 3.441

Review 8.  Toll-like receptors in urothelial cells--targets for cancer immunotherapy.

Authors:  Hélène LaRue; Cherifa Ayari; Alain Bergeron; Yves Fradet
Journal:  Nat Rev Urol       Date:  2013-08-27       Impact factor: 14.432

9.  Mycobacterial Infection of Precision-Cut Lung Slices Reveals Type 1 Interferon Pathway Is Locally Induced by Mycobacterium bovis but Not M. tuberculosis in a Cattle Breed.

Authors:  Aude Remot; Florence Carreras; Anthony Coupé; Émilie Doz-Deblauwe; Maria L Boschiroli; John A Browne; Quentin Marquant; Delphyne Descamps; Fabienne Archer; Abraham Aseffa; Pierre Germon; Stephen V Gordon; Nathalie Winter
Journal:  Front Vet Sci       Date:  2021-07-09

10.  Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium tuberculosis Virulence.

Authors:  Pauline Bade; Fabrizio Simonetti; Stephanie Sans; Patricia Laboudie; Khadija Kissane; Nicolas Chappat; Sophie Lagrange; Florence Apparailly; Christine Roubert; Isabelle Duroux-Richard
Journal:  Front Immunol       Date:  2021-06-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.